EMA consults on use of interactive response technologies in clinical trials
This article was originally published in SRA
Executive Summary
The European Medicines Agency is seeking feedback on a draft reflection paper that deals with the increasing use of interactive voice and web-based response systems (IVRS/IWRS) in clinical trials1.